CMAC has appointed John Mack as a new member of its Industry Board. Representing CMAC’s Tier 2 membership, John’s role will enhance the Tier 2 community's connection to CMAC’s activities, ensuring the centre stays at the forefront of manufacturing advancements and continues to meet the evolving needs of its members.
Read MoreTogether, CMAC and digiM will align to accelerate research and development within CMAC’s ambitious strategy for digital transformation of Chemistry, Manufacturing, and Control (CMC) processes.
Read MoreCMAC staff and students recently gathered at the Hilton Dunblane Hydro Hotel for CMAC’s annual Summer School, a week-long event featuring workshops, seminars, and networking opportunities.
Read MoreThe EPSRC MediForge Hub will transform the development and manufacturing of medicines by pioneering an Industry 5.0 manufacturing system for sustainable, resilient, and human-centric medicine production.
Read MoreCMAC are thrilled to announce that we have welcomed Malvern Panalytical as a new Tier 2 member within our cutting-edge technology portfolio.
Read MoreThis collaboration marks a significant milestone for the Centre in driving collaborative research and innovation within advanced pharmaceutical manufacturing.
Read MoreThe University of Strathclyde’s medicines manufacturing research centre, CMAC, is delighted to announce the next phase in our strategic partnership with The Glasgow School of Art (GSA).
Read MoreCMAC welcomed 288 delegates from 68 companies to the highly anticipated CMAC Open Days 2023, offering a platform for networking, dissemination and collaborative learning and exploration.
Read MoreSummer School is an annual, week-long programme that provides CMAC students and staff with the opportunity to collaborate with a variety of talented professionals who deliver insightful training throughout the week.
Read MoreIn celebration of International Day of Women and Girls in Science, we would like to recognise the valuable contributions that CMAC’s employees have made to the science and technology industry.
Read MoreSir Andrew Witty, chief executive officer (CEO) of GlaxoSmithKline visited the CMAC National Facility on Monday 22nd Feb 2016.
Read More
